Indium-111 labeled gold nanoparticles for in-vivo molecular targeting.

The present report describes the synthesis and biological evaluation of a molecular imaging platform based on gold nanoparticles directly labeled with indium-111. The direct labeling approach facilitated radiolabeling with high activities while maintaining excellent stability within the biological environment. The resulting imaging platform exhibited low interference of the radiolabel with targeting molecules, which is highly desirable for in-vivo probe tracking and molecular targeted tumor imaging. The indium-111 labeled gold nanoparticles were synthesized using a simple procedure that allowed stable labeling of the nanoparticle core with various indium-111 activities. Subsequent surface modification of the particle cores with RGD-based ligands at various densities allowed for molecular targeting of the αvß3 integrin in-vitro and for molecular targeted imaging in human melanoma and glioblastoma models in-vivo. The results demonstrate the vast potential of direct labeling with radioisotopes for tracking gold nanoparticles within biological systems.

[1]  Leaf Huang,et al.  Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. , 2009, Biochimica et biophysica acta.

[2]  J. Frangioni,et al.  In Vivo Tracking of Stem Cells for Clinical Trials in Cardiovascular Disease , 2004, Circulation.

[3]  Bengt Långström,et al.  Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development , 2003, European Journal of Clinical Pharmacology.

[4]  Paschalis Alexandridis,et al.  Block copolymer-directed metal nanoparticle morphogenesis and organization , 2011 .

[5]  R. Weissleder,et al.  Multivalent effects of RGD peptides obtained by nanoparticle display. , 2006, Journal of medicinal chemistry.

[6]  Ande Bao,et al.  In vivo PET imaging and biodistribution of radiolabeled gold nanoshells in rats with tumor xenografts. , 2010, International journal of pharmaceutics.

[7]  Hendrik Engelbrecht,et al.  Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer , 2012, Proceedings of the National Academy of Sciences.

[8]  Warren C W Chan,et al.  Effect of gold nanoparticle aggregation on cell uptake and toxicity. , 2011, ACS nano.

[9]  W. Weber,et al.  Novel 64Cu- and 68Ga-Labeled RGD Conjugates Show Improved PET Imaging of ανβ3 Integrin Expression and Facile Radiosynthesis , 2011, The Journal of Nuclear Medicine.

[10]  Lawrence Tamarkin,et al.  Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine , 2010, Clinical Cancer Research.

[11]  R. Hicks,et al.  Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy , 2010, Cancer imaging : the official publication of the International Cancer Imaging Society.

[12]  D. Wilbur,et al.  Radiohalogens for imaging and therapy. , 2005, Chemical Society reviews.

[13]  D. Cheresh,et al.  Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. , 1987, The Journal of biological chemistry.

[14]  P. Perriat,et al.  The biodistribution of gold nanoparticles designed for renal clearance. , 2013, Nanoscale.

[15]  J. Reubi,et al.  Affinity profiles for human somatostatin receptor subtypes SST1–SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use , 2000, European Journal of Nuclear Medicine.

[16]  D. Fernig,et al.  Robust ligand shells for biological applications of gold nanoparticles. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[17]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[18]  W. Cai,et al.  64Cu-Labeled Tetrameric and Octameric RGD Peptides for Small-Animal PET of Tumor αvβ3 Integrin Expression , 2007, Journal of Nuclear Medicine.

[19]  Karen L Wooley,et al.  Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy. , 2014, Angewandte Chemie.

[20]  Ralph Weissleder,et al.  Molecular imaging in the clinical arena. , 2005, JAMA.

[21]  Raffaella Barone,et al.  Experimental facts supporting a red marrow uptake due to radiometal transchelation in 90Y-DOTATOC therapy and relationship to the decrease of platelet counts , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[23]  I. Velikyan Molecular Imaging and Radiotherapy: Theranostics for Personalized Patient Management , 2012, Theranostics.

[24]  T. M. Day,et al.  Luminescent nanobeads: attachment of surface reactive Eu(III) complexes to gold nanoparticles. , 2006, Chemical communications.

[25]  J. Slot,et al.  A new method of preparing gold probes for multiple-labeling cytochemistry. , 1985, European journal of cell biology.

[26]  J. Schlenoff,et al.  Aggregation-resistant water-soluble gold nanoparticles. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[27]  David E Reichert,et al.  Metal complexes as diagnostic tools , 1999 .

[28]  Ingeborg Goethals,et al.  Nuclear medicine imaging to predict response to radiotherapy: a review. , 2003, International journal of radiation oncology, biology, physics.

[29]  M. Walter,et al.  The Influence of Different Metal-Chelators on the Biological Profile of Nanoparticles for Gallium-68 Based Molecular Imaging , 2012 .

[30]  Piotr Walczak,et al.  Personalized nanomedicine advancements for stem cell tracking. , 2012, Advanced drug delivery reviews.

[31]  H. Kessler,et al.  Radiolabelled RGD peptides for imaging and therapy , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[32]  E. Pauwels,et al.  18F-labeled radiopharmaceuticals for PET in oncology, excluding FDG. , 2000, Nuclear medicine and biology.

[33]  J. Marchalonis An enzymic method for the trace iodination of immunoglobulins and other proteins. , 1969, The Biochemical journal.

[34]  Dong Liang,et al.  Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. , 2009, Biomaterials.

[35]  D. Fernig,et al.  Determination of size and concentration of gold nanoparticles from UV-vis spectra. , 2007, Analytical chemistry.

[36]  Karen Weintraub,et al.  Biomedicine: The new gold standard , 2013, Nature.

[37]  A. Iagaru,et al.  Current concepts and future directions in radioimmunotherapy. , 2010, Current drug discovery technologies.

[38]  May D. Wang,et al.  In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags , 2008, Nature Biotechnology.

[39]  M. Hensler,et al.  Involvement of tumor cell integrin αvβ3 in hematogenous metastasis of human melanoma cells , 2004, Clinical & Experimental Metastasis.